BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 13329383)

  • 1. Behaviour in vitro of some new antistaphylococcal antibiotics.
    GARROD LP; WATERWORTH PM
    Br Med J; 1956 Jul; 2(4984):61-5. PubMed ID: 13329383
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro sensitivity of 300 strains of Micrococcus pyogenes isolated from carriers to seven antibiotics; the problem of the resistant Staphylococci in Chile.
    PAREDES L; VACCARO H; VALENZUELA E
    Antibiot Annu; 1955-1956; 3():623-33. PubMed ID: 13355339
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro activity against Micrococcus pyogenes of various combinations of antimicrobial agents.
    WAISBREN BA
    J Lab Clin Med; 1955 Oct; 46(4):583-91. PubMed ID: 13263739
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of fixed combinations of antibiotics on Staphylococci in vitro.
    FURESZ S; ZANGAGLIA O; SCOTTI R
    Antibiot Chemother (Northfield); 1958 Nov; 8(11):571-5. PubMed ID: 24544980
    [No Abstract]   [Full Text] [Related]  

  • 5. Novobiocin and PA 105: in vitro and in vivo studies on effectiveness against Micrococcus pyogenes.
    NOYES HE; NAGLE SC; SANFORD JP; ROBBINS ML
    Antibiot Chemother (Northfield); 1956 Jul; 6(7):450-5. PubMed ID: 24544026
    [No Abstract]   [Full Text] [Related]  

  • 6. The action of antibiotic combinations on pathogenic staphylococci in vitro.
    MANTEN A
    Antibiot Chemother (Northfield); 1956 Aug; 6(8):480-6. PubMed ID: 24544085
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the in vitro effectiveness of kanamycin and nine other antibiotics against staphylococci.
    GRIFFITH LJ; OSTRANDER WE
    Antibiot Chemother (Northfield); 1959 Jul; 9(7):416-8. PubMed ID: 24545275
    [No Abstract]   [Full Text] [Related]  

  • 8. [Conclusions drawn from in vitro studies on the pathogenicity of antibiotic resistant and sensitive Micrococcus pyogenes aureus strains cultivated from the excreta of tuberculotic patients].
    HAMPEL M
    Tuberkulozis; 1957; 10(7-9):204-5. PubMed ID: 13530260
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies in vitro on characteristics of a new antibiotic actinoxanthine].
    BUIANOVSKAIA IS; DMITRIEVA VS; CHAIKOVSKAIA SM; SEMENOV SM; ANDREEVA NA
    Antibiotiki (Mosc); 1958; 3(1):27-30. PubMed ID: 24544808
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of vancomycin, oleandomycin, and novobiocin and staphylococci in vitro.
    RANTZ LA; RANDALL E; THUM L; BARKER LF
    Antibiot Chemother (Northfield); 1957 Aug; 7(8):399-409. PubMed ID: 24544513
    [No Abstract]   [Full Text] [Related]  

  • 11. Vancomycin, a new antibiotic. II. In vitro antibacterial studies.
    MCGUIRE JM; WOLFE RN; ZIEGLER DW
    Antibiot Annu; 1955-1956; 3():612-8. PubMed ID: 13355337
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of a combination of sodium sulfisoxazole and oleandomycin phosphate on the development of drug resistance of Micrococcus pyogenes var. aureus in vitro.
    DELORENZO WF
    Antibiot Chemother (Northfield); 1958 Feb; 8(2):84-5. PubMed ID: 24544672
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotic combinations; antistreptococcal and antistaphylococcal activity of plasma of normal subjects after oral doses of penicillin, oleandomycin and combinations of these antibiotics.
    FINLAND M; JONES WF
    N Engl J Med; 1957 Jan; 256(3):115-9. PubMed ID: 13388042
    [No Abstract]   [Full Text] [Related]  

  • 14. The in vitro antibiotic activity of novobiocin on M. pyogenes and some intestinal gram-negative bacteria.
    COPPO A
    Antibiot Chemother (Northfield); 1957 Jun; 7(6):297-305. PubMed ID: 24544434
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synergism and antagonism of antibiotics; experimental research with Staphylococcus pyogenes aureus of Oxford].
    LENTI G; ODDONE I; FAZIO M; CALCIATI A; JONA E
    G Batteriol Immunol; 1955; 48(5-6):224-38. PubMed ID: 13277778
    [No Abstract]   [Full Text] [Related]  

  • 16. Selection of stable multiple antibiotic-resistant variants of Micrococcus pyogenes in the absence of antibiotics.
    FUSILLO MH
    Antibiot Chemother (Northfield); 1956 Feb; 6(2):125-9. PubMed ID: 24543914
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent changes in sensitivity of Micrococcus pyogenes to various antibiotic agents.
    NEEDHAM GM; NICHOLS DR
    J Lab Clin Med; 1953 Jan; 41(1):150-6. PubMed ID: 13023106
    [No Abstract]   [Full Text] [Related]  

  • 18. NEW ANTIBIOTICS in the fight against resistant staphylococci.
    Am J Pharm Sci Support Public Health; 1956 Sep; 128(9):300-4. PubMed ID: 13372757
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro sensitivity of erythromycin-resistant strains of staphylococci and enterococci to vancomycin and novobiocin.
    SCHNEIERSON SS; AMSTERDAM D
    Antibiot Chemother (Northfield); 1957 May; 7(5):251-4. PubMed ID: 24544426
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antagonism of action in vitro of tyrothricin combined with other antibiotics on isolated bacteria or mixtures of Schizomycetes and various fungi].
    DI BELLA A; MASONI S; ZULIANI F
    Boll Ist Sieroter Milan; 1955; 34(9-10):603-8. PubMed ID: 13293245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.